<i>CDKN2A</i> Alterations and Response to Immunotherapy in Solid TumorsElio Adib, David J. Kwiatkowski, Amin H. Nassar et al.|Clinical Cancer Research|2021Cited by 129
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H. Nassar, Alexander Gusev, Habib El‐Khoury et al.|Cancer Cell|2022Cited by 117
TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanismNicola Alesi, Elizabeth P. Henske, Elie W. Akl et al.|Nature Communications|2021Cited by 102
TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis ComplexNicola Alesi, Elizabeth P. Henske, Damir Khabibullin et al.|Nature Communications|2024Cited by 46
Identification of Loss-of-Function Granulin Mutation as a New Cause of Childhood Interstitial Lung Disease Responsive to Anti-TNF-Alpha BiologicsJohn C. Kennedy, Benjamin A. Raby, Nicola Alesi et al.|Unknown|2021Cited by 0